The largest database of trusted experimental protocols

S5 1 probe

Manufactured by Philips
Sourced in United States

The S5-1 probe is a medical imaging device manufactured by Philips. It is a transducer used in ultrasound imaging to capture high-quality images of internal body structures. The probe operates in the frequency range of 1-5 MHz and is designed for a variety of clinical applications.

Automatically generated - may contain errors

19 protocols using s5 1 probe

1

Echocardiographic Assessment of Ventricular Dimensions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Philips iE33 ultrasonic diagnostic apparatus and S5-1 probe (both from Philips Medical Systems, Inc., Bothell, WA, USA) with a frequency of 2–4 MHz were used to conduct M-type-sampling on the standard left ventricular short axis mitral valve under the guidance of the two-dimensional echocardiography, to ensure the sample line be vertical to the ventricular septal posterior wall, measuring LVEDD, LVESD, and automatically outputting LVED according to the Teichholz correction formula (9 (link)). The samples were measure three times and the average was taken.
+ Open protocol
+ Expand
2

Echocardiographic Evaluation of LV Function

Check if the same lab product or an alternative is used in the 5 most similar protocols
A Philips iE33 system (Philips Medical, Best, Netherlands) equipped with an s5-1 probe (12-14 MHz) was used to measure the left ventricular end-diastolic diameter (LVEDD) and left ventricular end-systolic diameter (LVESD). A computer algorithm was used to assess the left ventricular ejection fraction (LVEF) and left ventricular fraction shortening (LVFS).
+ Open protocol
+ Expand
3

Contrast-Enhanced Ultrasound Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
Microbubble contrast suspension containing 8 μl (45 μg) of sulfur hexafluoride per ml (Third Military Medical University) was injected (1 ml/kg, both mCEUS groups) via the tail vein [18 (link)]. Continuous or intermittent mCUES was applied to each rat for a period of 10 min via a Philips IE33 (USA) ultrasonic diagnostic machine with an S5-1 probe (harmonic frequency, 1.7/3.3 MHz; mechanical index, 0.8 mI; and treatment time, 10 min) [19 (link)].
+ Open protocol
+ Expand
4

Echocardiographic Evaluation of CHD

Check if the same lab product or an alternative is used in the 5 most similar protocols
All subjects were examined by ultrasound within 12 h of admission using the iE33 color Doppler ultrasound machine (Phillips) with a S5-1 probe and a probe frequency of 3–4 MHz. Dynamic echocardiography of the left ventricle was performed for five consecutive cardiac cycles on patients in the left recumbent position. Images of the aortic valve orifice, left ventricular outflow tract, and mitral orifice blood flow vein were collected, and measurements of the mitral orifice’s early-to-late diastolic blood flow velocity ratio (E/A), left ventricular end-diastolic volume (LVDd), and left atrial diameter (LAD) were recorded. Targeted treatment was provided according to the conditions of the patients with CHD.
+ Open protocol
+ Expand
5

Comprehensive Echocardiographic Evaluation of Cardiac Function

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data on conventional transthoracic echocardiography (TTE) including TDI measurements were directly acquired from clinical records. A GE Vivid E9 imaging system (GE Vingmed Ultrasound, Horten, Norway) equipped with a probe M5S (2, 4 MHz), or a Philips IE33 imaging algorithm (Philips Healthcare, Andover, MA, USA) with a S5-1 probe (2.5, 3.5 MHz) was employed. All echocardiographic data were collected according to the guidelines of the American Society of Echocardiography (ASE).
LVEF was measured based on the modified method of biplane Simpson’s. TDI measurements including systolic velocity (s’), early (e’), and late (a’) diastolic velocities were recorded at the septal mitral annulus in apical 4-chamber view (13 (link)). The transmitral to mitral annular early diastolic velocity ratio (E/e’) was calculated (14 (link),15 (link)). We also defined the ratio of early and late diastolic velocities as the e’/a’ ratio (16 (link)). Ratios of E/e’ and e’/a’ represented measures of left ventricular filling pressure and diastolic performance, respectively. EAS index, a novel parameter calculated as e’/(a’ × s’), is a combined assessment of cardiac systolic and diastolic function (7 (link),17 (link)).
+ Open protocol
+ Expand
6

Echocardiographic Assessment of Left Atrial Appendage

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transthoracic echocardiography (TTE) was performed with a Philips EPIQ7c ultrasonic diagnostic instrument, S5-1 probe and probe frequency 1–5 MHz. Parameters such as left ventricular ejection fraction (measured by the biplane Simpson's method) were recorded in detail in the left recumbent position. TEE was examined by PhilipsiE33 color Doppler ultrasonography with an X7-2t transesophageal matrix real-time three-dimensional probe with a frequency of 2–7 MHz. Before fasting for 6–8 h, the ECG was recorded synchronously, the pulsed Doppler sampling volume was placed within 1 pulse near the opening of the left atrial appendage, and the blood flow spectrum of the left atrial appendage was obtained. The left atrial appendage blood flow spectrum was a regular two-way wave in sinus rhythm and an irregular zigzag waveform in atrial fibrillation rhythm. The peak value of the positive wave, that is, the maximum emptying velocity of the left atrial appendage, was recorded in 3 and 10 cardiac cycles, respectively, and the average value was taken as the velocity of the left atrial appendage (LAA-FV) (Fig. 12).

The blood flow pattern of the left atrial appendage in sinus rhythm.

The blood flow pattern of the left atrial appendage in atrial fibrillation rhythm.

+ Open protocol
+ Expand
7

Echocardiographic Assessment of Left Ventricular Function

Check if the same lab product or an alternative is used in the 5 most similar protocols
A Philips EPIQ7 echocardiograph equipped with an S5-1 probe (frequency 1–5 MHz) and frame rate ≥60 beats/min was used. When performing echocardiography, patients should remain in the left lateral position and maintain calm breathing. A synchronized electrocardiogram was connected to an ultrasound machine. The left ventricular end diastolic diameter (LVDd), left ventricular end systolic diameter (LVDs), interventricular septum diameter (IVSd) and left ventricular posterior wall diameter (LVPWd) were measured in each patient, representing the end-diastolic/systolic anteroposterior diameter of left ventricular, left ventricular end-diastolic septal thickness, and left ventricular end-diastolic posterior wall thickness, respectively. The ratio of E/A and E/e' were used to estimate LV diastolic function, where E and A are early and late transmitral flow velocities, and e' is early diastolic septal tissue velocity. Left ventricular ejection fraction (LVEF) was measured using the modified Simpson biplane method.
+ Open protocol
+ Expand
8

Comprehensive Cardiac Ultrasound Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
A Philips EPIQ 7c ultrasonic diagnostic apparatus, S5-1 probe, and probe with a frequency 1–5 MHz were used. The patient was placed in the left decubitus position, and the patient’s left atrium anteroposterior diameter, left ventricular end-diastolic diameter, left ventricular ejection fraction (measured by biplane Simpson method), left ventricular posterior wall thickness, ventricular septal thickness and other parameters were recorded in detail. The Devereux formula [14 (link)] was used to calculate the left ventricular mass index (LVMI), as follows: LVMI (g/m2) = LVM (calculated by 0.8 × 1.04 [(IVSd + PWTd + LVDd)3 − LVDd3] + 0.6)/BSA (calculated by 0.006 × height (cm) + 0.013 × body weight (kg) − 0.153).
+ Open protocol
+ Expand
9

Fetal Echocardiographic Evaluation of TAPSE and Tei Index

Check if the same lab product or an alternative is used in the 5 most similar protocols
A PhilipsEPIQ7C diasonograph (Philips, Amsterdam, the Netherlands) was used with a C5-1 probe of frequency 1 to 5 MHz and an S5-1 probe of frequency 1 to 5 MHz. A GE VolusonE10 diasonograph (GE, Tiefenbach, Austria), C5-1 probe with frequency 1 to 5 MHz, and C9-2 probe with frequency 2 to 9 MHz were used for the following: (1) routine fetal ultrasound examination excluding malformations and verified fetal gestational age; (2) fetal echocardiography excluding structural abnormalities in the fetal heart; (3) measurement of the TAPSE value, showing the standard four-chambered heart. The position of the probe was adjusted to move the tip forward or backward, the M-type ultrasound mode was initiated, the sampling line was placed at the tangent position at the junction of the anterior lobe ring and the right ventricular free wall, the angle of the longitudinal movement was adjusted to < 15°, and the distance from the lowest point of movement to the highest was measured (Figs. 1A, 1B); (4) tissue doppler imaging (TDI) was obtained by the tricuspid ring movement spectrum of the mitral lobe at the anterior lobe and the valve ring junction. The scan speed was adjusted to the maximum, and the Tei index was measured (Figs. 2A, 2B). All data were measured for the three stable cardiac cycles, and the averages were recorded.
+ Open protocol
+ Expand
10

Ultrasound Imaging with SonoVue Contrast

Check if the same lab product or an alternative is used in the 5 most similar protocols
A Philips IE Elite ultrasound diagnostic instrument with an S5-1 probe at 2.5 to 3.5 MHz was used in this study, and the data analysis was completed using offline Q-Lab 9.0 software. The ultrasound contrast agent used was SonoVue (Bracco, Italy).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!